[HTML][HTML] Therapeutic host-directed strategies to improve outcome in tuberculosis

C Young, G Walzl, N Du Plessis - Mucosal immunology, 2020 - Elsevier
Abstract Bacille Calmette-Guérin (BCG) is the only licenced tuberculosis (TB) vaccine, but
has limited efficacy against pulmonary TB disease development and modest protection …

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences

A Aiello, S Najafi-Fard, D Goletti - Frontiers in Immunology, 2023 - frontiersin.org
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) and Coronavirus disease-
2019 (COVID-19), whose etiologic agent is severe acute respiratory syndrome coronavirus …

Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung

P Ogongo, LB Tezera, A Ardain… - The Journal of …, 2021 - Am Soc Clin Investig
T cell immunity is essential for the control of tuberculosis (TB), an important disease of the
lung, and is generally studied in humans using peripheral blood cells. Mounting evidence …

[HTML][HTML] Cytokine storm in tuberculosis and IL-6 involvement

FG Boni, I Hamdi, LM Koundi, K Shrestha… - Infection, Genetics and …, 2022 - Elsevier
Tuberculosis is probably the most seasoned illness of the humanity. Intricacies or
subsequent death emerging from these infections are frequently connected with cytokine …

Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity

P Sampath, A Rajamanickam, K Thiruvengadam… - Scientific Reports, 2023 - nature.com
Tuberculosis (TB) elimination is possible with the discovery of accurate biomarkers that
define the stages of infection. Drug-resistant TB impair the current treatment strategies and …

Identification of immune biomarkers in recent active pulmonary tuberculosis

SN Shaukat, E Eugenin, F Nasir, R Khanani… - Scientific reports, 2023 - nature.com
Tuberculosis (TB) has remained an unsolved problem and a major public health issue,
particularly in developing countries. Pakistan is one of the countries with the highest …

Randomized trial of metformin with anti-tuberculosis drugs for early sputum conversion in adults with pulmonary tuberculosis

C Padmapriydarsini, M Mamulwar… - Clinical Infectious …, 2022 - academic.oup.com
Background Metformin, by reducing intracellular Mycobacterium tuberculosis growth, can be
considered an adjunctive therapy to anti-tuberculosis treatment (ATT). We determined …

Superinfection with SARS-CoV-2 has deleterious effects on Mycobacterium bovis BCG immunity and promotes dissemination of Mycobacterium tuberculosis

RE Hildebrand, SS Chandrasekar, M Riel… - Microbiology …, 2022 - Am Soc Microbiol
An estimated one-third of the world's population is infected with Mycobacterium tuberculosis,
with the majority being vaccinated with Mycobacterium bovis BCG. Severe acute respiratory …

Ghrelin as an anti-inflammatory and protective agent in ischemia/reperfusion injury

K Raghay, R Akki, D Bensaid, M Errami - Peptides, 2020 - Elsevier
Abstract Ischemia/reperfusion (I/R) continue to be the most frequent cause of damaged
tissues. Injured tissues resulted from the first ischemic insult, which is determined by the …

Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis

NP Kumar, K Moideen, A Nancy, V Viswanathan… - Scientific reports, 2019 - nature.com
Plasma cytokines are biomarkers of disease extent and mycobacterial burden in pulmonary
tuberculosis (PTB). Whether chemokines can perform the same role in PTB is not known. We …